BioSpace News Archive

Packaging of pharmaceutical products is considered to be a very crucial element for the pharmaceutical industry because such packaging ensures the quality and safety of drugs that it contains.

The global market for cleanroom consumables has expanded rapidly in the past few years.

Intersect ENT, Inc. announced the results of a United Kingdom-based independent analysis measuring costs and patient outcomes of the PROPEL steroid releasing sinus implant compared to a non-drug-eluting spacer following endoscopic sinus surgery for patients with chronic sinusitis.

BioInvent International AB, a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, announces the enrollment of the first patient in a Phase I/IIa clinical trial of BI-1206 in combination with anti-PD-1 therapy KEYTRUDA® for patients with solid tumors.

Century Therapeutics Canada will develop induced pluripotent Stem Cell (iPSC)-derived allogeneic immune cell therapies against glioblastoma (GBM)

Moleculin Biotech, Inc., a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, announced that Walter Klemp, Chairman and Chief Executive Officer, will present at the Life Sciences Investor Forum being held virtually on June 25th, 2020 at 1:30pm ET.

- U.S. Government will support the scale-up of INOVIO’s proprietary intradermal DNA delivery device CELLECTRA® 3PSP to deliver INOVIO’s COVID-19 vaccine - INOVIO to report on interim U.S. Phase 1 clinical trial results in late June - INOVIO preparing for U.S. Phase 2/3 efficacy study to begin this summer [23-June-2020] PLYMOUTH MEETING, Pa. , June 2

Research Presented at 2020 AACR Virtual Annual Meeting The Triple I/O Combination of Plinabulin, Anti-PD-1 and Radiation Achieved a 100 Percent Complete Response in Anti-PD-1 Non-responsive Animal Model Triple I/O Combination to Be Administered to Patients Who Failed I/O in Second Half of 2020 NEW YORK, June 23, 2020 (GLOBE NEWSWIRE) -- BeyondSpring (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative immuno-

Study Shows Low Incidence of Toxicity Using Stereotactic Body Radiation Therapy (SBRT) While Reducing Potential Complications Associated with Implanted Markers

Bantec, Inc. ( OTCPINK: BANT ) (“Bantec” or the “Company”) , Bantec, Inc., a product and services company, announces that it expanded its offerings with CleanSmart. Bantec will now market and sell robotics that ultimately help businesses and building owners combat Covid-19. The robots possess the ability to communicate n